Scalable Multiplexed Drug-Combination Screening Platforms Using 3D Microtumor Model for Precision Medicine

Zhixiong Zhang, Yu Chih Chen, Sumithra Urs, Lili Chen, Diane M. Simeone, Euisik Yoon

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cancer heterogeneity is a notorious hallmark of this disease, and it is desirable to tailor effective treatments for each individual patient. Drug combinations have been widely accepted in cancer treatment for better therapeutic efficacy as compared to a single compound. However, experimental complexity and cost grow exponentially with more target compounds under investigation. The primary challenge remains to efficiently perform a large-scale drug combination screening using a small number of patient primary samples for testing. Here, a scalable, easy-to-use, high-throughput drug combination screening scheme is reported, which has the potential of screening all possible pairwise drug combinations for arbitrary number of drugs with multiple logarithmic mixing ratios. A “Christmas tree mixer” structure is introduced to generate a logarithmic concentration mixing ratio between drug pairs, providing a large drug concentration range for screening. A three-layer structure design and special inlets arrangement facilitate simple drug loading process. As a proof of concept, an 8-drug combination chip is implemented, which is capable of screening 172 different treatment conditions over 1032 3D cancer spheroids on a single chip. Using both cancer cell lines and patient-derived cancer cells, effective drug combination screening is demonstrated for precision medicine.

Original languageEnglish
Article number1703617
JournalSmall
Volume14
Issue number42
DOIs
Publication statusPublished - 2018 Oct 18

Fingerprint

Precision Medicine
Preclinical Drug Evaluations
Drug Combinations
Medicine
Screening
Neoplasms
Pharmaceutical Preparations
Cells
Oncology
Therapeutics
Throughput
Costs and Cost Analysis
Cell Line
Testing
Costs

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biomaterials
  • Chemistry(all)
  • Materials Science(all)

Cite this

Zhang, Zhixiong ; Chen, Yu Chih ; Urs, Sumithra ; Chen, Lili ; Simeone, Diane M. ; Yoon, Euisik. / Scalable Multiplexed Drug-Combination Screening Platforms Using 3D Microtumor Model for Precision Medicine. In: Small. 2018 ; Vol. 14, No. 42.
@article{6cd4ee3530b440ceaf367d7e8dd05319,
title = "Scalable Multiplexed Drug-Combination Screening Platforms Using 3D Microtumor Model for Precision Medicine",
abstract = "Cancer heterogeneity is a notorious hallmark of this disease, and it is desirable to tailor effective treatments for each individual patient. Drug combinations have been widely accepted in cancer treatment for better therapeutic efficacy as compared to a single compound. However, experimental complexity and cost grow exponentially with more target compounds under investigation. The primary challenge remains to efficiently perform a large-scale drug combination screening using a small number of patient primary samples for testing. Here, a scalable, easy-to-use, high-throughput drug combination screening scheme is reported, which has the potential of screening all possible pairwise drug combinations for arbitrary number of drugs with multiple logarithmic mixing ratios. A “Christmas tree mixer” structure is introduced to generate a logarithmic concentration mixing ratio between drug pairs, providing a large drug concentration range for screening. A three-layer structure design and special inlets arrangement facilitate simple drug loading process. As a proof of concept, an 8-drug combination chip is implemented, which is capable of screening 172 different treatment conditions over 1032 3D cancer spheroids on a single chip. Using both cancer cell lines and patient-derived cancer cells, effective drug combination screening is demonstrated for precision medicine.",
author = "Zhixiong Zhang and Chen, {Yu Chih} and Sumithra Urs and Lili Chen and Simeone, {Diane M.} and Euisik Yoon",
year = "2018",
month = "10",
day = "18",
doi = "10.1002/smll.201703617",
language = "English",
volume = "14",
journal = "Small",
issn = "1613-6810",
publisher = "Wiley-VCH Verlag",
number = "42",

}

Scalable Multiplexed Drug-Combination Screening Platforms Using 3D Microtumor Model for Precision Medicine. / Zhang, Zhixiong; Chen, Yu Chih; Urs, Sumithra; Chen, Lili; Simeone, Diane M.; Yoon, Euisik.

In: Small, Vol. 14, No. 42, 1703617, 18.10.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Scalable Multiplexed Drug-Combination Screening Platforms Using 3D Microtumor Model for Precision Medicine

AU - Zhang, Zhixiong

AU - Chen, Yu Chih

AU - Urs, Sumithra

AU - Chen, Lili

AU - Simeone, Diane M.

AU - Yoon, Euisik

PY - 2018/10/18

Y1 - 2018/10/18

N2 - Cancer heterogeneity is a notorious hallmark of this disease, and it is desirable to tailor effective treatments for each individual patient. Drug combinations have been widely accepted in cancer treatment for better therapeutic efficacy as compared to a single compound. However, experimental complexity and cost grow exponentially with more target compounds under investigation. The primary challenge remains to efficiently perform a large-scale drug combination screening using a small number of patient primary samples for testing. Here, a scalable, easy-to-use, high-throughput drug combination screening scheme is reported, which has the potential of screening all possible pairwise drug combinations for arbitrary number of drugs with multiple logarithmic mixing ratios. A “Christmas tree mixer” structure is introduced to generate a logarithmic concentration mixing ratio between drug pairs, providing a large drug concentration range for screening. A three-layer structure design and special inlets arrangement facilitate simple drug loading process. As a proof of concept, an 8-drug combination chip is implemented, which is capable of screening 172 different treatment conditions over 1032 3D cancer spheroids on a single chip. Using both cancer cell lines and patient-derived cancer cells, effective drug combination screening is demonstrated for precision medicine.

AB - Cancer heterogeneity is a notorious hallmark of this disease, and it is desirable to tailor effective treatments for each individual patient. Drug combinations have been widely accepted in cancer treatment for better therapeutic efficacy as compared to a single compound. However, experimental complexity and cost grow exponentially with more target compounds under investigation. The primary challenge remains to efficiently perform a large-scale drug combination screening using a small number of patient primary samples for testing. Here, a scalable, easy-to-use, high-throughput drug combination screening scheme is reported, which has the potential of screening all possible pairwise drug combinations for arbitrary number of drugs with multiple logarithmic mixing ratios. A “Christmas tree mixer” structure is introduced to generate a logarithmic concentration mixing ratio between drug pairs, providing a large drug concentration range for screening. A three-layer structure design and special inlets arrangement facilitate simple drug loading process. As a proof of concept, an 8-drug combination chip is implemented, which is capable of screening 172 different treatment conditions over 1032 3D cancer spheroids on a single chip. Using both cancer cell lines and patient-derived cancer cells, effective drug combination screening is demonstrated for precision medicine.

UR - http://www.scopus.com/inward/record.url?scp=85053762435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053762435&partnerID=8YFLogxK

U2 - 10.1002/smll.201703617

DO - 10.1002/smll.201703617

M3 - Article

C2 - 30239130

AN - SCOPUS:85053762435

VL - 14

JO - Small

JF - Small

SN - 1613-6810

IS - 42

M1 - 1703617

ER -